Sharemaestro Newsreel

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts

Simulations Plus, Inc. (NASDAQ:SLP) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $17.25, below its opening price of $18.32. This comes despite the company exceeding quarterly earnings expectations with an EPS of $0.30 and revenue of $21.89 …

Evolent Health (NYSE:EVH) Reports Bullish Q2 CY2026, Stock Jumps 18.2%

Talkspace, Inc. (Nasdaq: TALK) posts Q2 loss as UHS deal looms

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

Omada Health (OMDA) Earnings Date and Reports 2026

Omada Health members rose 45%; CEO change planned for Jan. 1

Phreesia schedules Sept. 2 call to discuss fiscal Q2 results

CareCloud Reports Second Quarter 2026 Results

CareCloud, Inc. (Nasdaq: CCLD) announced its financial results for the second quarter of 2026, reporting a 16% increase in revenue to $31.9 million and its ninth consecutive quarter of positive GAAP net income. The company also expanded into the compliance and audit-defense market through …

CareCloud, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCLD) 2026-08-06

CareCloud (NASDAQ:CCLD) Issues Quarterly Earnings Results

CareCloud Inc (CCLD) Earnings Forecast: Future EPS & Revenue Growth Estimates

American Well (AMWL) Stock Rally Turns On Near Breakeven EBITDA

Privia Health (PRVA) Misses Q2 Earnings Estimates

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) Earnings Date and Reports 2026 $DOCS

So-Young International Inc (SY) Earnings Forecast: Future EPS & Revenue Growth Estimates

So-Young International Inc (SY) has an earnings forecast score of 9.00, ranking 7th in the Software & IT Services industry, with an average analyst price target of $7.65. Analysts maintain a "Strong Buy" rating for SY. The company's expected revenue for the next quarter …

Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift – Has The Bull Case Changed?

Schrödinger, Inc. reported strong Q2 2026 results with a shift to profitability and a significant expansion of its AI co-scientist collaboration with Bristol Myers Squibb. This deal, involving the new agentic AI Bunsen, reinforces the company's AI-driven growth ambitions and its computational platform's growing …

Utah Lab and Nuclea Explore Morpheus Test-Reactor Site

Mangoceuticals' merger partner, Nuclea Energy USA, has signed a Memorandum of Understanding (MOU) with the Utah Office of Energy Development to explore siting a nuclear test reactor for its Morpheus microreactor at the Utah San Rafael Energy Lab. This agreement is a significant step …

LifeMD (NASDAQ:LFMD) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

LifeMD (NASDAQ:LFMD) reported its quarterly earnings, missing analyst expectations with an adjusted EPS of negative $0.16 against a consensus of negative $0.15, and revenue of $47.28 million, falling short of the $49.16 million estimate. The telehealth company also reduced its full-year 2026 guidance due …

LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss

LifeMD (NASDAQ:LFMD) reported disappointing Q2 2026 results, missing both revenue and non-GAAP EPS consensus estimates. The virtual care and pharmacy services company posted revenue of $47.3 million against a $50.1 million consensus, and a non-GAAP loss per share of $0.16 compared to an expected …

LifeMD (NASDAQ: LFMD) posts Q2 $47.3M revenue, cuts 2026 guidance

LifeMD reported Q2 2026 telehealth revenue of $47.3 million, a 4% year-over-year decrease, though within guidance, as it transitions weight-management patients to branded GLP-1 therapies and longer subscriptions. The company increased active subscribers by 20% to approximately 356,000, and gross margin expanded to 89%. …

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

Mangoceuticals (MGRX) stock surged over 49% after hours following news that its merger partner, Nuclea Energy Inc., through its subsidiary Nuclea Energy USA Inc., signed a memorandum of understanding with Utah's Office of Energy Development. This MOU explores siting a nuclear test reactor for …

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger (Nasdaq: SDGR) announced its second quarter 2026 financial results, reporting ACV of $29.6 million, a 27% increase year-over-year, and total revenue of $58.9 million, an 8% increase. The company also launched an early access version of Bunsen, its new agentic AI co-scientist for …

LifeMD earnings missed by $0.06, revenue fell short of estimates

CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary

CARLSMED, INC. reported its Q2 2026 financial results, with revenue increasing by 56.7% year-over-year to $18.94M. Despite this growth, the company recorded a net loss of $(10.51M) and a diluted loss per share of $(0.39). Key drivers for revenue growth included increased procedure volumes …

LifeMD Q2 Results: Revenue falls 3%, adjusted EBITDA loss widens

LifeMD reported a 3% year-over-year revenue decline to $47.3 million in Q2 2026, while its adjusted EBITDA swung to a $3.5 million loss, primarily due to higher customer acquisition costs and a strategic shift to branded GLP-1 therapies. Despite the revenue dip, gross margin …

HeartBeam, Inc. (BEATW) Analyst insights, Price targets and Recommendations

The article provides analyst insights, price targets, and recommendations for HeartBeam, Inc. (BEATW). It includes current stock performance, related tickers, and general market data. The stock BEATW is shown to be trading at $0.0150, down 30.23% at market close on August 7.

Price to earnings forward of Heartbeam, Inc. – NASDAQ:BEATW

This article provides financial information for Heartbeam, Inc. (NASDAQ:BEATW), specifically focusing on its Price to Earnings (forward) metric. It is presented through TradingView, noting that the market is currently closed with no trades. The content highlights the company's financial data and general market information …

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on 15 analysts, the stock has a "Hold" rating, with an average price target of $5.00. The expected revenue for …

Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results

Schrodinger (NASDAQ:SDGR) announced quarterly earnings results, significantly surpassing analyst expectations with an EPS of $0.08 against an estimated loss of $0.41, and revenue of $58.89 million, exceeding estimates of $47.19 million. The company's software annual contract value grew 27%, driven by large pharmaceutical, biotech, …

GoodRx (NASDAQ:GDRX) Posts Earnings Results, Hits Estimates

Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours

LifeMD (LFMD) reported a Q2 revenue miss of $47.3 million against an analyst forecast of $49.15 million, alongside an adjusted EBITDA loss and a lowered full-year 2026 outlook, causing shares to drop over 17% in after-hours trading. Despite the financial setbacks, the company highlighted …

BlackRock, Inc. Adds to Talkspace Inc (TALK) Stake -- Shares Loo

BlackRock, Inc. increased its stake in Talkspace Inc (TALK) by purchasing an additional 710,562 shares at $5.20 each, bringing its total holdings to over 11.1 million shares. This move reflects BlackRock's confidence in the virtual behavioral healthcare provider, despite Talkspace shares appearing approximately 26% …

Healthequity Inc stock hits 52-week high at 106.42 USD By Investing.com

Healthequity Inc (HQY) stock reached a new 52-week high of $106.42, demonstrating a 15.42% positive change over the past year and a 32.5% return in the last six months. This surge follows strong Q1 fiscal year 2027 results, surpassing market expectations for EPS and …

Certara Announces Leadership Change in Commercial Executive Role

Certara, Inc. announced that Leif E. Pedersen has departed from his role as President and Chief Commercial Officer, effective August 1, 2026. Pedersen will remain as a Senior Advisor through December 31, 2026, to facilitate the transition, and will receive severance benefits as per …

Transcript : Carlsmed, Inc., Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript for Carlsmed, Inc.'s Q2 2026 Earnings Call held on August 5, 2026. It also includes recent news and analyst ratings concerning Carlsmed, such as Truist adjusting its price target and Needham initiating coverage. The content emphasizes that the full …